跳至主要内容
临床试验/CTRI/2025/08/092320
CTRI/2025/08/092320尚未招募3 期

Clinical study to evaluate the efficacy of Navayas Lauha in the management of Garbhini Pandu w.s.r to Iron deficiency Anemia in Pregnancy

Dr Anju Yadav1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年8月15日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
Improvement in haemoglobin parameter

研究概览

简要总结

Due to the predominance of paleness all over the body it is named as pandu roga. The patient in whom dosas with predominance of pitta are vitiated in dhatus is affected with the Laxity of  dhatus and heaviness in body .Complexion strength ,unctuousness and other properties also get too much

diminished due to morbidity of Dosa and dusya .Thus she gets affected with deficiency of blood

,fat,ojas,looseness of bodyparts and abnormality of complexion. There are several drugs for garbhini pandu but here I have chosen Navayas lauh with Madhu and ghrit as it acts as rasayan and uttam raktavridhikara. Therefore I have selected 40 patients aged between 20-40 years, Patient should be selected on the basis of inclusion and exclusion criteria. The trial will be of 3 consecutive months and  follow up will be done after 15 days then after each month. Cured after 3 months patient gets 80-100 percent relie from signs and symptoms.

研究设计

研究类型
Interventional
分配方式
Other
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 40.00 Year(s)(—)
性别
Female

入选标准

  • Pregnant woman age group 20-40 yrs 1st,2nd and 3rd trimester Primi and multigravida both Hb% between 7gm % to 10 gm %.

排除标准

  • Age below 20 year and above 40 year All type of anemia other than iron deficiency Anemia All patient in high risk pregnancy group other than iron deficiency Anemia All major systemic disease Hb gm % below 7gm % and above 10 gm %.

结局指标

主要结局

Improvement in haemoglobin parameter

时间窗: The trial drug will be given for 3 months with anupana and follow up will be done after cessation of medicine in 4 months

次要结局

  • Reduction of pallor,fatigue and loss of appetite and palpitation(After analyzing all the parameters the result will be assessed on the basis of symptomatic relief and improvement)

研究者

发起方
Dr Anju Yadav
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Anju Yadav

Vaidya Yagya dutt Sharma Ayurved Mahavidyalaya

研究点 (1)

Loading locations...

相似试验